Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Nina Rehnqvist"'
Autor:
Nina Rehnqvist, Claes Held, Paul Hjemdahl, I. Björkander, Ewa Billing, Sven V. Eriksson, Per Näsman, Lennart Forslund, Thomas Kahan
Publikováno v:
European Journal of Clinical Investigation. 43:141-151
Background Although stable angina pectoris often carries a favourable prognosis, it remains important to identify patients with an increased risk of cardiovascular (CV) complications. Many new markers of disease activity and prognosis have been descr
Autor:
Nina Rehnqvist, Måns Rosén, Karl A. Franklin, Bengt Haglund, Susanna Axelsson, Thorbjörn Holmlund
Publikováno v:
Acta Oto-Laryngologica. 131:298-302
No case of death related to surgery in the form of uvulopalatopharyngoplasty, uvulopalatoplasty or nasal surgery for snoring or sleep apnea has been recorded in Sweden among 4876 patients treated between 1997 and 2005. Severe complications of surgery
Autor:
Berit Mørland, Nina Rehnqvist, Marjukka Mäkelä, Ruairidh Milne, Julia Chamova, Sun Hae Lee-Robin, Claudia Wild, Finn Børlum Kristensen, Susanna Allgurin Neikter, Lise Lund Håheim, Camilla Nielsen, Mireia Espallargues, Reinhard Busse
Publikováno v:
International Journal of Technology Assessment in Health Care. 25:107-116
Objectives: The European network on Health Technology Assessment (EUnetHTA) aimed to produce tangible and practical results to be used in the various phases of health technology assessment and to establish a framework and processes to support this. T
Publikováno v:
Acta Medica Scandinavica. 223:431-435
We studied the influence of beta-adrenoceptor blockade on heart rate responses to facial immersion in ice-cooled water after acute myocardial infarction. Forty patients with acute myocardial infarction were randomized to the double-blind therapy with
Autor:
Gunnar L. Olsson, Nina Rehnqvist
Publikováno v:
Acta Medica Scandinavica. 220:33-38
The Stockholm Metoprolol Trial is a prospective double-blind placebo-controlled postmyocardial infarction study of 301 patients treated with metoprolol, 100 mg b.i.d., or matching placebo for three years. From this study we have retrospectively evalu
Autor:
Göran Ulvenstam, Erling Bae, Reidar Bjørnerheim, Fred‐Arne Halvorsen, Olavi Keyriläinen, Ulf Rosenqvist, Jan Engvall, Nina Rehnqvist, Johan Lyng, Anders Åberg, Risto Härkönen, Arto Uusitalo, Penti Rautio, Gunnar Nyberg
Publikováno v:
Acta Medica Scandinavica. 223:219-225
The anti-anginal effect of a controlled-release (Durules) formulation of isosorbide-5-mononitrate (5-ISMN) 60 mg, Imdur, once daily was evaluated in a randomised double-blind, placebo-controlled, crossover study with a placebo run-in period. Each per
Autor:
Leif Rw Erhardt, Nina Rehnqvist, Carl‐Göran Ericsson, Göran Svensson, Bo Lindvall, Gunnar L. Olsson, Lars‐Eric Strandberg
Publikováno v:
Acta Medica Scandinavica. 224:507-513
Data on the 2,008 patients in the Swedish Co-operative Study from 1969 were compared with 773 consecutive cases with definite myocardial infarction (MI) admitted to the coronary care unit (CCU) of Danderyd Hospital in Stockholm 1984-85. We found a si
Publikováno v:
Acta Medica Scandinavica. 219:147-152
Twenty patients on chronic beta-blockade for angina pectoris were included in a double-blind randomized cross-over placebo-controlled study on a 2% nitroglycerin gel administered transdermally by an adhesive. Topinitro. The dose, 2.5-10 mg/day, was i
Autor:
Nina Rehnqvist, Thomas Kahan, Lennart Forslund, Mats Ericson, Paul Hjemdahl, I. Björkander, Claes Held
Publikováno v:
Cardiology. 111:126-133
Objectives: To examine the usefulness of time domain heart rate variability (HRV) measurements by a simple graphical method, the differential index (DI), in prognostic assessments of patients with chronic stable angina pectoris. Methods: HRV measurem
Publikováno v:
Lakartidningen. 112